<div id="readability-page-1"><p>Corebridge Financial Inc. decreased its position in  GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.0% during the first quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 137,670 shares of the company's stock after selling 4,289 shares during the quarter. Corebridge Financial Inc.'s holdings in GE HealthCare Technologies were worth $11,111,000 as of its most recent SEC filing.</p><ul><li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li></ul><p>Other institutional investors have also recently bought and sold shares of the company. LGT Financial Advisors LLC boosted its holdings in  GE HealthCare Technologies by 46.2% during the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after acquiring an additional 123 shares during the period.  Integrated Wealth Concepts LLC boosted its stake in  GE HealthCare Technologies by 0.7% during the 4th quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company's stock valued at $1,343,000 after purchasing an additional 126 shares during the period.  Knuff &amp; Co LLC boosted its stake in  GE HealthCare Technologies by 1.5% during the 1st quarter. Knuff &amp; Co LLC now owns 10,276 shares of the company's stock valued at $829,000 after purchasing an additional 150 shares during the period.  Graypoint LLC grew its holdings in  GE HealthCare Technologies by 5.7% in the 1st quarter. Graypoint LLC now owns 3,028 shares of the company's stock valued at $244,000 after buying an additional 162 shares during the last quarter.  Finally, Ferguson Wellman Capital Management Inc. increased its position in  GE HealthCare Technologies by 3.2% in the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company's stock worth $431,000 after buying an additional 166 shares during the period. Institutional investors own  82.06% of the company's stock. </p><h2>GE HealthCare Technologies Stock Down 0.7%</h2><p>Shares of GEHC opened at $74.09 on Wednesday. The company has a market capitalization of $33.83 billion, a P/E ratio of 15.18, a PEG ratio of 2.85 and a beta of 1.13. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The business's 50 day simple moving average is $74.10 and its 200-day simple moving average is $74.95. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. </p><ul><li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li></ul><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business's revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.  GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts predict that  GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year. </p><h2>GE HealthCare Technologies Dividend Announcement</h2><p>The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio  is 2.87%. </p><ul><li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li></ul><p>GE HealthCare Technologies announced that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that authorizes the company to buyback $1.00 billion in  outstanding  shares. This buyback authorization authorizes the company to reacquire up to 3.1% of its shares through open market purchases. Shares buyback programs are often an indication that the company's leadership believes its shares are undervalued. </p><h2>Analyst Ratings Changes</h2><p>Several equities research analysts have recently weighed in on GEHC shares. Morgan Stanley lowered their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Thursday, July 31st. Evercore ISI reduced their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an &#34;outperform&#34; rating for the company in a report on Thursday, May 1st. The Goldman Sachs Group dropped their price objective on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a &#34;buy&#34; rating on the stock in a report on Thursday, May 1st. Citigroup increased their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, July 31st. Finally, UBS Group raised GE HealthCare Technologies from a &#34;sell&#34; rating to a &#34;neutral&#34; rating and decreased their target price for the stock from $74.00 to $73.00 in a research report on Monday, May 5th. Eight investment analysts have rated the stock with a Buy rating and three have issued  a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $88.55.</p><p><b>Get Our Latest Report on GEHC</b></p><h2>GE HealthCare Technologies Company Profile</h2> (Free Report)<p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p><h2>Read More</h2><ul><li>Five stocks we like better than GE HealthCare Technologies</li><li>2 Fintech Stocks to Buy Now and 1 to Avoid</li><li>As Trump Blocks Clean Energy, What's Next for Renewables?</li><li>How to Calculate Retirement Income: MarketBeat’s Calculator</li><li>How a Superstore Strategy Fueled MINISO’s 20% Stock Surge</li><li>How to Short Nasdaq: An Easy-to-Follow Guide</li><li>Analysts Love These 3 Companies Reporting Earnings This Week</li></ul><p><strong>Want to see what other hedge funds are holding GEHC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

GEHC

CRBG

<p>Corebridge Financial Inc. has reduced its stake in GE HealthCare Technologies Inc. by 3.0%, now holding 137,670 shares valued at $11.11 million. Other institutional investors have also adjusted their positions. GE HealthCare's stock is currently down 0.7%, with a market cap of $33.83 billion and a P/E ratio of 15.18. The company reported a quarterly EPS of $1.06, exceeding estimates, and announced a quarterly dividend of $0.035 per share. Analysts have varied price targets for GEHC, reflecting differing outlooks on the stock's performance.</p>

Corebridge Financial Inc. Has $11.11 Million Stake in GE HealthCare Technologies Inc. $GEHC